Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.
Vivencio BarriosSergio Cinza-SanjurjoJavier García-AlegríaRomán Freixa-PamiasFrederic Llordachs-MarquesCarlos A MolinaAmparo Santamaría OrtizDavid VivasCarmen Suárez FernandezPublished in: Future cardiology (2022)
Compared with face-to-face consultations, telemedicine has many advantages, including more efficient use of healthcare resources, partial relief of the burden of care, reduced exposure to COVID-19, treatment adjustment, organization of more efficient healthcare circuits and patient empowerment. Ensuring optimal anticoagulation in atrial fibrillation patients is mandatory if we want to reduce the thromboembolic risk. Of note, telemedicine is an excellent option for the long-term management of atrial fibrillation patients. Moreover, direct oral anticoagulants may provide an added value in telemedicine (versus vitamin K antagonists), as it is not necessary to monitor anticoagulant effect or make continuous dosage adjustments. In this multidisciplinary consensus document, the role of telemedicine in anticoagulation of this population is discussed and practical recommendations are provided.
Keyphrases
- atrial fibrillation
- direct oral anticoagulants
- healthcare
- venous thromboembolism
- left atrial
- oral anticoagulants
- end stage renal disease
- catheter ablation
- left atrial appendage
- newly diagnosed
- heart failure
- chronic kidney disease
- ejection fraction
- coronavirus disease
- percutaneous coronary intervention
- prognostic factors
- sars cov
- clinical practice
- acute coronary syndrome
- case report
- palliative care
- health information
- risk factors
- mitral valve
- patient reported